It is introduced to the patient’s immune system, causing the production and presentation of tumor antigens to CD8+ and CD4+ T cells, engaging both the innate and adaptive immunities and leading to the development of immunological memory in the case of tumor relapse [23]. This evidence concerns the gene CD8A and neoplasm.